Electrochemical detection of gliclazide and Glibenclamide (cas 10238-21-8) on ZnIn2S4 nanoparticles-modified carbon ionic liquid electrode
-
Add time:07/24/2019 Source:sciencedirect.com
This research introduces a new modification of carbon paste electrode (CPE) by ZnIn2S4 nanoparticles (ZIS) and an ionic liquid (1-butyl-3-methylimidazolium hexafluorophosphate, (BMIM.PF6)) as a sensitive sensor for voltammetric detection of gliclazide and Glibenclamide (cas 10238-21-8) compared to unmodified carbon paste electrode. The modified electrode (ZISILCPE) was characterized by different techniques such as cyclic voltammetry (CV), differential pulse voltammetry (DPV) and chronoamperometry (CHA). The electrochemical parameters of gliclazide were studied on the modified electrode surface. It was revealed that the performance of ZISILCPE sensor toward electrochemical detection of gliclazide and glibenclamide has significantly improved, in aqueous solution. The electrocatalytic features of the modified sensor were further exploited for the detection of gliclazide by DPV as a sensitive detection method. The sensor showed two well-expressed voltammetric peaks for two targets, and successfully resolved the overlap of corresponding voltammetric responses. Based on DPV, there was a linear increase for the peak currents from gliclazide and glibenclamide respectively with their concentrations ranging from 7.5 × 10−7–5.0 × 10−4 M to 1.0 × 10−6–8.0 × 10−4 M. According to the ZISILCPE, gliclazide and glibenclamide demonstrated the detection limits of 1.2 × 10−7 M and 8.0 × 10−7 M, respectively. The offered protocol was also efficient to detect two analytes in pharmaceuticals and urine samples.
We also recommend Trading Suppliers and Manufacturers of Glibenclamide (cas 10238-21-8). Pls Click Website Link as below: cas 10238-21-8 suppliers
Prev:Studying tautomerism in an important pharmaceutical Glibenclamide (cas 10238-21-8) confined in the thin nanometric layers
Next:Role of AKR1C3 in renal injury and Glibenclamide (cas 10238-21-8) is anti-inflammatory in preeclamptic rats) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Characterization and evaluation of different mesoporous silica kinds as carriers for the development of effective oral dosage forms of Glibenclamide (cas 10238-21-8)07/31/2019
- Controlled release of Glibenclamide (cas 10238-21-8) from monolithic silica subdermal implants produced by the sol-gel process and its use for hyperglycaemia treatment in a murine model07/30/2019
- Effects of dexmedetomidine and MK-467 on plasma glucose, insulin and glucagon in a Glibenclamide (cas 10238-21-8)-induced canine hypoglycaemia model07/29/2019
- Peceosomes for oral delivery of Glibenclamide (cas 10238-21-8): In vitro in situ correlation07/28/2019
- Low-voltage online stimulated microextraction of Glibenclamide (cas 10238-21-8) from whole blood07/27/2019
- Neuroprotective potential of Glibenclamide (cas 10238-21-8) is mediated by antioxidant and anti-apoptotic pathways in intracerebral hemorrhage07/26/2019
- Role of AKR1C3 in renal injury and Glibenclamide (cas 10238-21-8) is anti-inflammatory in preeclamptic rats07/25/2019
- Studying tautomerism in an important pharmaceutical Glibenclamide (cas 10238-21-8) confined in the thin nanometric layers07/23/2019